cgs 26393 has been researched along with Angiospasm, Intracranial in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chang, CZ; Howng, SL; Jeng, AY; Kassell, NF; Kwan, AL; Lee, KS; Lin, CL; Savage, P; Winardi, D; Wu, SC; Yen, CP | 1 |
1 other study(ies) available for cgs 26393 and Angiospasm, Intracranial
Article | Year |
---|---|
Oral administration of an inhibitor of endothelin-converting enzyme attenuates cerebral vasospasm following experimental subarachnoid haemorrhage in rabbits.
Topics: Administration, Oral; Animals; Aspartic Acid Endopeptidases; Basilar Artery; Dose-Response Relationship, Drug; Endothelin-Converting Enzymes; Enzyme Inhibitors; Metalloendopeptidases; Organophosphonates; Rabbits; Subarachnoid Hemorrhage; Tetrazoles; Vasospasm, Intracranial | 2002 |